NK and T cells play a pivotal role in host defence to Cryptococcus neoformans (C. neoformans) fungus which affects especially hosts with impaired cell mediated immunity. The vaccine against cryptococcosus is not developed yet, thus we established an animal BALB/c mice model to analyse anticryprococcal activity of immune cells. We detected that non-stimulated spleen mononuclear cells (MNC) from non-immunized mice have the capacity to exhibit anticriptococcal activity on the incapsulated C. neoformans strain (ATCC 34873) and this activity can be enhanced by non-adherent cells (NAC). In order to obtained antigen-specific anticryprococcal activity, MNC and NAC were stimulated in vitro with corpuscular (Ag1) or soluble (Ag2) C. neoformans antigen prepared from the acapsular strain Cap67 (ATCC 52817). In vitro stimulation of immune cells with both C. neoformans antigens enhanced the anticryptococcal activity of MNC and NAC. NAC fraction expressed the highest anticryptococcal activity, also in the presence and in the absence of accessory cells (AC). The highest anticryptococcal activity of effector cells was detected after immunization of mice with the same C. neoformans antigens and after additional stimulation of immune cells in vitro with
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INTRODUCTION
Cryptococcus neoformans (C. neoformans) is one of the most common fungi which cause invasive fungal infections in patients with compromised cell-mediated immunity, including AIDS (Coker, 1992) . The importance of cellmediated immunity and CD4+T lymphocytes in host resistance against C. neoformans is well documented and is exemplified by the high susceptibility to progressive infection with this pathogen in AIDS patients with reduced CD4+T cells (Mitchell and Perfect, 1995) . Although CD4+ cells are critically important for immune responses and host defence to C. neoformans, both CD4+ and CD8+ T cells are involved in the generation of the protective immune response (Huffnagle et al., 1991) . However, in vivo CD8+ cells depletion abrogated host defence to C. neoformans in comparison with CD8+ cells undepleted mice and rats (Arsi}, 1993; 1997) , suggesting that CD8+ T cells contribute to the protective immune response. This raises the possibility to protect hosts with deficiency of CD4+ cells, such as in AIDS, by designing immunization strategies for stimulating cytotoxic immune cells. Also, some studies have demonstrated that murine NK cells in vitro bind to and kill C. neoformans (Hidore et al., 1991) and that NK cells are effective in the clearance of cryptococci from the tissues of infected mice (Hidore and Murphy, 1986) . It is known that anticryptococcal activity of NK cells is constitutively expressed and mediated dominantly by perforin, while CD8+ T cells require prior activation with C. neoformans and is mediated with granulysin expression (Ma et al., 2004) . Recently it was showed that in murine non-adherent cells anticryptococcal cytotoxicity is perforin and non-perforin medated (Petkovi} et al., 2010) . According to data which demonstrated that preimmunization with heat-killed C. neoformans significantly prolonged the survival time of mice (Kawakami et al., 1995) and that mice genetically engineered to lack CD4+ T cells could be successfully vaccinated to develop resistance to C. neoformans (Aguirre et al., 2004 ) the aims of this study were to compare the role of corpuscular and soluble C. neoformans antigens for immunization and growth inhibition of C. neoformans and to design a simple and reproducible animal model for further studies and immunization strategies against human cryptococcosus.
MATERIAL AND METHODS

Animals.
A total of 60 pathogen free female BALB/c mice, 6-8 weeks old, 29±6.4 g, were obtained from the animal colony maintained at the Institute of Microbiology and Immunology, Medical faculty, University of Ljubljana, Slovenia. The study protocol was performed according to International Statutes on Animal Experiments and approved by The Ethics Committee of Medical faculty, University of Ljubljana, Slovenia.
Microbial strains. C. neoformans strain Cap67, unencapsulated mutant of B3501 (ATCC 52817) was used for the isolation of cryptococcal antigens (Ag1 and Ag2), immunization and in vitro challenge study. The encapsulated serotypes D strain B3501 (ATCC 34873), which is the isogenic parent strain of Cap67, can cause human infection via the pulmonary route, was utilized in the in vitro growth inhibition assay. The strains were obtained from the American Type Culture Collection (Manassas, VA) and were maintained on Sabourad dextrose agar (SDA) and passed to fresh slants every month, as previously described (Mody et al., 1989) .
Preparation of C. neoformans antigens. Corpuscular (Ag1) and soluble (Ag2) antigens were prepared for the study. Heat-killed cells of C. neoformans Cap67 (Ag1) were prepared as previously described (Muth and Murphy, 1995) . Supernatant of heat-killed C. neoformans Cap67 (Ag2) was prepared during the same procedure: C. neoformans Cap67 was grown for 96 h, washed three times, resuspended at 1 x 10 9 /mL and the suspension of cryptococci was heat killed in phosphate-buffered saline (PBS) (pH 7.2) at 80 o C for 1 h. The heat-killed C. neoforman was concentrated by centrifuging at 2000 x g for 10 min and the supernatant (Ag2) was removed, filtered over a 0.2 mm filter pore and stored at -70 o C. Study design and immunization protocols. First group of mice (n=5) was immunized with C. neoformans Ag1 by intraperitoneal (ip) injection of suspension containing 5 x 10 7 C. neoformans cells, and the second group (n=5) was immunized with C. neoformans Ag2 (0.5 mL) by ip injection. Five days later the first group was boosted by ip injection containing 5 x 10 8 C. neoformans Ag1 and the second group was boosted by ip injection containing 1.0 mL C. neoformans Ag2. Control mice (n=5) were injected with an equal volume of PBS (pH 7.2) by the same routes. Eight days later the mice were sacrificed, spleens were removed and effector cell prepared.
Effector cells preparations. Immune effector cells were prepared from the spleens which were first mechanically disrupted. The mononuclear cells (MNC) were obtained after centrifugation at 800 x g for 20 minutes over a Ficoll density gradient and suspended in RPMI 1640 (5% fetal calf serum, 2 mM glutamine, 100 U/mL penicillin G, 0.1 mg streptomycin) (Sigma-Aldrich, Austria). To separated non-adherent cells (NAC) the MNC were passed over a nylon wool column and the efficacy of adherence to nylon wool was evaluated by flow cytometry. Stimulation of effector cell populations (5 x 10 5 /well) with C. neoformans Ag1 or with C. neoformans Ag2 was done in 96-wells plates in quadruplicate for 24 h. Non-stimulated or C. neoformans Ag1/C. neoformans Ag2 stimulated effector cells used for anticryptococcal activity were: (i) MNC, (ii) NAC with accessory cells (AC), (iii) NAC without of AC.
Immunofluorescent labelling and flow cytometry. The efficacy of separation of effector cell population was evaluated by flow cytometry. Monoclonal antibodies (mAb) were used to identify cell populations after the separation on nylon wool. Effector cells population was labelled with FITC-conjugated anti-CD3 and anti-CD86 mAb and with PE-conjugated anti-CD19, anti-CD49b mAb (Becton Dickinson, USA). After 1 h of incubation the labelled cells were washed twice and then analyzed by FACSCalibur flow cytometer and CELLQuest software (Becton Dickinson). NK and T cells are labelled with anti-CD49b and anti-CD3 mAb. B cells and AC such as macrophages or other APC are labelled with anti-CD19 and anti-CD86 mAb.
Growth inhibition assay of C. neoformans. For the growth inhibition assay we used the human pathogen C. neoformans encapsulated strain serotype D B3501 (ATCC 34873) which is the isogenic parent strain of Cap 67 (ATCC 52817). C. neoformans was maintained on SDA and log-phase yeasts were harvested by suspension in RPMA 1640 medium, washed and then counted on a 
RESULTS AND DISCUSSION
MNC and NAC from non-immunized mice express anticryptococcal activity after in vitro stimulation with Ag1 or Ag2.
In the initial experiments we tested the antifungal activity of spleen MNC and demonstrated that cells from nonimmunized mice in vitro stimulated with C. neoformans Ag1 or with C. neoformans Ag2 express antifungal activity (Fig. 1A) . To obtain NAC, spleen MNC was treated with nylon wool and the separation efficiency for CD3+ cells was 79.1 +/-2.3%, while for CD49b+ cells was 7.9 +/-0.5, confirmed with flow cytometry. Anticryptococcal effect of NAC was tested and observed growth inhibition assay of C. neoformans was stronger compared to MNC (Fig 1B) . Further in vitro stimulation of NAC with C. neoformans Ag1 or C. neoformans Ag2 showed higher anticryptococcal activity compared to non-stimulated NAC (Fig 1C) . Data showed that MNC and NAC from non-immunized animals exhibit anticryptococcal activity, and furthermore the NAC are capable to be in vitro activated with different C. neoformans Ag.
After immunization MNC and NAC express higher anticryptococcal activity. Highest anticryptococcal activity was observed after in vitro incubation of effector cells with Ag1 or Ag2 in the presence of APC. In order to determine whether in vivo immunization enhances the ability of MNC and NAC anticryptococcal activity, we compared activities of immune cells obtained from Ag1 or Ag2 immunized mice. MNC from immunized mice exerted 2-3 fold higher growth inhibition of C. neoformans compared to MNC from non-immunized mice (data not shown). Relative to the results obtained from non-immunized mice (Fig. 1C) further we tested the inhibition capacity of NAC from immunized mice by using the same protocol. Results showed that the anticryptococcal activity mediated by NAC from immunized mice was significantly higher compared to anticryptococcal activity of NAC obtained from non-immunized mice (Fig. 2) , and also with presence of AC less than 1%. In non-immunized animals corpuscular Ag1 showed a better activity (p>0.05; not significant). The best anticryptococcal activity was observed with MNC and NAC obtained from immunized mice further stimulated with the same antigens by which the immunization was done (p<0.05; significant), as well as with soluble Ag2 (Fig. 2) .
Our data is in correlation with previous reports that growth inhibition of C. neoformans is mediated by NAC and that anticryptococcal activity is enhanced by immunization with heat-killed C. neoformans (Fromtling et al., 1983; Levitz et al., 1995; Murphy et al., 1998 ), but we also found that: (i) immunization with soluble antigens (Ag2) can enhance the antifungal activity of MNC and also of NAC which can be activated in vitro in the presence or absence of AC, (ii) immunization resulted in enhanced anticryptococcal activity and this effect was highest when immunization and further in vitro stimulations were done with the same antigens (iii) the animal model is simple and reproducible and can be useful for further studies and immunization strategies against human cryptococcosis.
It has been known that freshly isolated T cells and NK cells from lymphoid tissues of normal, non-immunized mice have the capacity to bind C. neoformans in vitro and inhibit the growth of C. neoformans (Levitz et al., 1994) . Our results have shown that spleen MNC from non-immunized mice are capable to be activated in vitro with either Ag1 or Ag2 and exert enhanced antifungal activity compared to non-activated cells (Fig 1A) . After nylon wool depletion of adherent cells the anti-cryptococcal activity mediated by NA cells was higher (Fig 1B) . We demonstrated that NA cells from non-immunized mice were activated directly in vitro by fungal molecules to enhance antifungal activity ( Fig 1C) . As shown in Fig.  1 the antifungal activity was enhanced independent of which C. neoformans antigens were used. As the NA cells separated by passage over nylon wool were depleted of AC and mice have not been exposed to C. neoformans before the experiment, we assume that responding cells for anticryptococcal activity were NK cells and/or naïve cytotoxic T lymphocytes.
Previous investigations demonstrated that both cell populations can inhibit in vitro growth of C. neoformans (Hidore et al., 1990) . It has been shown that C. %' CFU inhibition neoformans contains a mitogen able to stimulate naive T cells (Mody et al., 1999) and also that murine NK cells, human primary NK cells and the human NK cell line constitutively expressed anticryptococcal activity (Ma et al., 2004) . Therefore, T lymphocytes and NK cells can be activated directly by Ag1 and Ag2 C. neoformans and subsequently exert antifungal activity. Further, we demonstrated that growth inhibition of C. neoformans is enhanced by immunization either with corpuscular or soluble antigens (Fig 2) . Antifungal activity of spleen MNC was additionally enhanced after in vitro stimulation. The highest inhibition of fungal growth was detected when cells were in vitro stimulated with the same antigens that we used for immunization. Heatkilled cells of the unencapsulated mutant of B3501 (Cap 67) of C. neoformans (Ag1) (Muth and Murphy, 1995) or supernatant of heat-killed Cap 67 (Ag2) were used for immunization of BALB/c mice and in vitro cultivated with NA cells. The anticryptococcal activity of NA cells was tested for in vitro growth inhibition assay for C. neoformans. Besides, the well known role of heat-killed corpuscular antigen (Ag1) in immunization and stimulation of effectors cells showed that the supernatant of heat killed C. neoformans (Ag2) can stimulate the NA cells mediated anticryptococcal response. It was known that there are two major antigen fractions of C. neoformans: glucuronoxylomannan (GXM) and mannoproteins (MPs). GXM is a primary component of the polysaccharide capsule and is the major virulence factor which has an immunosuppressive role during the immune response (Yauch et al., 2006; Villena et al., 2008) . In contrast, MPs are present in the unencapsulated strain and have been identified as the key antigen that stimulate T-cell responses (Wozniak and Levitz, 2009 ). In accordance with this we prepared Ag1 and Ag2 from an unencapsulated Cap67 mutant of C. neoformans to stimulate NA cells in our model. Alongside this, the encapsulated strain serotype D (B3501) was utilised in the growth inhibition assay as encapsulated strains cause human infection.
The importance of NK cells for immunization effects and anticryptococcal activity has already been demonstrated (Marr et al., 2009 ), but enhanced anticryptococcal activity in our model can be ascribed to both NK cells and to mitogenic activity of C. neoformans on naïve T cells. Therefore, the antifungal activity of in vitro stimulated NA cells was dependent on the presence of expanded cytotoxic cells (Petkovi} et al., 2010) .
The described animal model is more simple and reproducible then models of in vivo infections with viable C. neoformans (Arsi} et al., 1993; 1997) . Taken together, our data suggest that immunization could hold promise in the setting of cryptococcosis, and that efficacy could depend on immunomodulation of the natural immune response of the host. In this study we employed an animal model to investigate the efficacy of immunization on anticryptococcal activity mediated with NA cells. Further investigations are needed to establish the function of the recapitulation of natural immunity and a better understanding of natural resistance to cryptococcosis. If the anticryptococcal mechanisms mediated with cytotoxic immune cells could be enhanced, it may be possible to create human vaccines and/or therapy strategies in the protection against C. neoformans in patients with a reduced number of CD4+ lymphocytes.
In summary, the data presented here demonstrated that soluble antigens also possess the capacity to enhance anticryptococcal activity. This is confirmed by the simple and reproducible animal model which can be useful for further evaluation of immunization and cellular immune response.
